A kind of lacidipine silica gel adsorption solid dispersion and its preparation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHENYANG PHARMA UNIVERSITY
- Publication Date
- 2016-08-31
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine, and in particular relates to a lacidipine silica gel adsorption solid dispersion and a preparation method thereof. Background technique
[0002] Lacidipine is a new type of long-acting dihydropyridine calcium channel blocker, its chemical name is (E)-4-[2-[3-(carboxy tert-butyl)-3-oxo-1- Propyl]phenyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridine-diethyl carboxylate, the structural formula is as follows. Lacidipine is highly selective, acting on smooth muscle calcium channels, mainly expanding peripheral arteries, reducing peripheral resistance, and has a strong and lasting antihypertensive effect. It has no significant effect on the cardiac conduction system and myocardial systolic function. And can improve the diastolic function of the damaged hypertrophic left ventricle, and anti-atherosclerosis. It is relatively safe for elderly patients with coronary heart disease, heart failure, renal insuffic...